Compare
Up to four compounds, side by side.
Useful for choosing between similar peptides or planning a stack.
Add a peptide
| Attribute | GLP-1 Agonist Liraglutide |
|---|---|
| Summary | The original FDA-approved daily GLP-1 for weight loss. |
| Mechanism | Long-acting GLP-1 agonist that slows gastric emptying and reduces appetite. |
| Top outcomes |
|
| Evidence | established |
| Half-life | ~13 hours |
| Administration | subq |
| Legal status | rx only |
| Safety | Nausea, GI upset on titration; pancreatitis warning; thyroid C-cell tumors in rodents. |